Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Recruiting

Phase 2

Gardasil9Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Sponsor:

University of Maryland, Baltimore

Code:

NCT06624839

Conditions

Human Papilloma Virus

Anal Dysplasia

HIV

Eligibility Criteria

Sex: Male

Age: 18 - 70

Healthy Volunteers: Accepted

Interventions

Human papillomavirus (HPV) vaccine, 9-valent

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-12. This information was provided to ClinicalTrials.gov by University of Maryland, Baltimore on 2026-08-05.